Stalevo Indications/Uses

carbidopa + levodopa + entacapone

Manufacturer:

Novartis Indonesia

Marketer:

Wellesta

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Stalevo is indicated for the treatment of patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase DDC inhibitor treatment.

Daftar Gratis untuk melanjutkan membaca

Lanjutkan dengan Google

Daftar dengan email

Sudah punya akun? Masuk